Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain Male Patients: A Crossover, Double-Blind, Placebo-Controlled Trial.

Libat Weizman, Haggai Sharon, Lior Dayan, Joumana Espaniol, Silviu Brill, Hadas Nahman‐Averbuch, Talma Hendler, Giris Jacob

CNS Drugs May 1, 2024 DOI: 10.1007/s40263-024-01085-0 (opens in new tab) via PubMed

Summary

AI-generated from the abstract

In male patients with chronic radicular neuropathic pain, a single sublingual dose of THC (0.2 mg/kg) shifted autonomic balance toward increased parasympathetic tone, as shown by a reduced low/high frequency heart rate variability ratio, and improved the body's ability to inhibit pain, measured by conditioned pain modulation. These changes correlated with increased functional connectivity between brainstem and prefrontal cortex regions, suggesting THC exerts top-down regulatory effects that may normalize multiple aspects of supraspinal pain dysregulation.

Study at a glance

Characteristics Randomized, double-blind, crossover, placebo-controlled, single-administration trial Peer reviewed
Sample size 12
Population Male patients with chronic radicular neuropathic pain
Intervention δ-9-tetrahydrocannabinol (THC)
Dose 0.2 mg/kg oral THC
Duration Single administration
Registration NCT02560545
Key finding THC significantly reduced the LF/HF heart rate variability ratio and significantly improved conditioned pain modulation responses compared with placebo.

Abstract

Disordered autonomic nervous system regulation and supraspinal pain inhibition have been repeatedly described in chronic pain. We aimed to explore the effects of δ-9-tetrahydrocannabinol (THC), an emerging treatment option, on autonomic nervous system and central pain modulation measures in patients with chronic pain. Twelve male patients with chronic radicular neuropathic pain participated in a randomized, double-blind, crossover, placebo-controlled, single-administration trial. Low/high frequency (LF/HF) heart rate variability (HRV) ratio and conditioned pain modulation (CPM) response were measured and resting-state functional magnetic resonance imaging (MRI) was performed at baseline and after sublingual administration of either 0.2 mg/kg oral THC or placebo. THC significantly reduced the LF/HF ratio compared with placebo (interaction effect F(1,11) = 20.5; p < 0.005) and significantly improved CPM responses (interaction effect F(1,9) = 5.2; p = 0.048). The THC-induced reduction in LF/HF ratio correlated with increased functional connectivity between the rostral ventrolateral medulla and the dorsolateral prefrontal cortex [T(10) = 6.4, cluster p-FDR < 0.005]. THC shifts the autonomic balance towards increased parasympathetic tone and improves inhibitory pain mechanisms in chronic pain. The increase in vagal tone correlates with connectivity changes in higher-order regulatory brain regions, suggesting THC exerts top-down effects. These changes may reflect a normalizing effect of THC on multiple domains of supraspinal pain dysregulation. NCT02560545.

Comments

No comments yet.

Log in to comment